As on Wednesday, Ardelyx Inc (NASDAQ: ARDX) started slowly as it slid -8.92% to $8.48, before settling in for the price of $9.31 at the close. Taking a more long-term approach, ARDX posted a 52-week range of $3.16-$10.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 146.90%. Meanwhile, its Annual Earning per share during the time was 28.61%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -22.55%. This publicly-traded company’s shares outstanding now amounts to $232.45 million, simultaneously with a float of $224.94 million. The organization now has a market capitalization sitting at $1.98 billion. At the time of writing, stock’s 50-day Moving Average stood at $7.69, while the 200-day Moving Average is $5.99.
Ardelyx Inc (ARDX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Ardelyx Inc’s current insider ownership accounts for 3.86%, in contrast to 58.74% institutional ownership. According to the most recent insider trade that took place on May 03 ’24, this organization’s insider sold 45,000 shares at the rate of 9.00, making the entire transaction reach 405,000 in total value, affecting insider ownership by 267,993. Preceding that transaction, on May 03 ’24, Company’s Chief Medical Officer sold 39,949 for 8.35, making the whole transaction’s value amount to 333,574. This particular insider is now the holder of 370,189 in total.
Ardelyx Inc (ARDX) Earnings and Revenue Records
Ardelyx Inc’s EPS decrease for this current 12-month fiscal period is -22.55% and is forecasted to reach 0.12 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 30.00% through the next 5 years, which can be compared against the 28.61% growth it accomplished over the previous five years trading on the market.
Ardelyx Inc (NASDAQ: ARDX) Trading Performance Indicators
Let’s observe the current performance indicators for Ardelyx Inc (ARDX). It’s Quick Ratio in the last reported quarter now stands at 4.36. The Stock has managed to achieve an average true range (ATR) of 0.53. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 12.47.
In the same vein, ARDX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.29, a figure that is expected to reach -0.11 in the next quarter, and analysts are predicting that it will be 0.12 at the market close of one year from today.
Technical Analysis of Ardelyx Inc (ARDX)
Through scrutinizing the latest numbers posted by the [Ardelyx Inc, ARDX], it can be observed that its last 5-days Average volume of 10.66 million was better the volume of 6.29 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 89.12% While, its Average True Range was 0.59.
Raw Stochastic average of Ardelyx Inc (ARDX) in the period of the previous 100 days is set at 64.55%, which indicates a major fall in contrast to 72.58% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 112.76% that was higher than 84.05% volatility it exhibited in the past 100-days period.
